Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00216931

Enrollment

Registered

2005-09-22

Start date

2006-05-31

Completion date

2008-10-31

Last updated

2009-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Pulmonary Hypertension, Respiratory Distress Syndrome

Brief summary

The purpose of this study is to determine if iloprost is effective in the treatment of elevated arterial pulmonary pressure in children with ventilator treated respiratory distress syndrome.

Interventions

DRUGiloprost

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

24 Hours to 48 Hours

Healthy volunteers

Inclusion criteria

* Elevated arterial pulmonary pressure * GA \> 24 GW * 24-48 hours of age * Ventilator treatment

Exclusion criteria

* Congenital anomalies * Severe hypotension

Design outcomes

Primary

Measure	Time frame
Oxygenation index	—
Cardiac output	—

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026